Transcriptional Profiling Shows Dampening of Interferon Gene Signatures by NAD+ Augmentation in Ataxia-Telangiectasia
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27135652 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Veronica Suaste und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences, University of Oslo, 0317 Oslo, Norway. Hauptthemen laut MEDLINE: NAD, Gene Expression Profiling, Ataxia Telangiectasia, Interferons. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, The Research Council of Norway, Euripean Union - Marie Sklodowska-Curie Action.
Abstract (Originalsprache)
Ataxia-Telangiectasia (A-T) is a multisystem disorder caused by loss of A-T mutated (ATM) protein activity, characterized clinically by immunodeficiency and cerebellar ataxia. ATM is a master regulator of DNA damage responses and loss of ATM function is accompanied by persistent activation of PARP1 leading to depletion of intracellular NAD+ and dysfunction of a series of cellular signalling pathways dependent on NAD+, providing a mechanistic rationale for NAD+ augmentation therapy. We performed a clinical trial of NAD+ augmentation with nicotinamide riboside (NR) over 24 months in A-T patients where we observed improved coordination and eye movements in A-T patients. Here, by using peripheral blood mononuclear cells, we performed longitudinal transcriptome profiling to define molecular signatures of A-T and to assess pathway-level responses to NR supplementation. A-T patients exhibited reproducible transcriptomic alterations involving immune, vascular, and inflammatory pathways. NAD+ augmentation was associated with suppression of interferon response genes and modulation of networks correlated with neurological improvement. These findings establish systemic molecular signatures of A-T and identify potential blood-based biomarkers that reflect disease processes and therapeutic response, supporting the use of NAD+ augmentation as a disease-modifying strategy in A-T by dampening interferon signalling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biosciences, University of Oslo, 0317 Oslo, Norway.
- Department of Microbiology, Oslo University Hospital, 0424 Oslo, Norway.
- Institute of Clinical Medicine, University of Oslo, Norway and CRESCO-Centre for Embryology and Healthy Development, 0316 Oslo, Norway.
- Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway.
- Department of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, 1478 Lørenskog, Norway.
- Norwegian National Unit for Newborn Screening, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, 0373 Oslo, Norway.
ORCID-Profile: Veronica Suaste, Rebecca Presterud, Anna B Wennerström, He-Ling Wang, Jianying Zhang, Solveig Osnes Lund, Torben Lüders, Lisa Lirussi, Lene Alsøe, Evandro Fei Fang, Asbjørg Stray-Pedersen, Hilde Loge Nilsen
Förderung
- Wellcome Trust
- The Research Council of Norway
- Euripean Union - Marie Sklodowska-Curie Action
- KLINSK BEHANDLINGSFORSKNING
- KLINISK behandlingsforskning
- Research Council of Norway
- European Union’s Horizon 2020 research and innovation programme
- Nasjonalforeningen for folkehelsen of Norway
Zitieren
APA
Suaste, V., Presterud, R., Wennerström, A. B., Wang, H. L., Zhang, J., Lund, S. O., Holmen, H. G., Lüders, T., Rowe, A., Berge, R. K., Lirussi, L., Lefol, Y., Alsøe, L., Fang, E. F., Stray-Pedersen, A., & Nilsen, H. L. (2026). Transcriptional Profiling Shows Dampening of Interferon Gene Signatures by NAD+ Augmentation in Ataxia-Telangiectasia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27135652
Vancouver
Suaste V, Presterud R, Wennerström AB, Wang HL, Zhang J, Lund SO, et al. Transcriptional Profiling Shows Dampening of Interferon Gene Signatures by NAD+ Augmentation in Ataxia-Telangiectasia. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27135652
BibTeX
@article{Suaste2026,
author = {Suaste, Veronica and Presterud, Rebecca and Wennerström, Anna B and Wang, He-Ling and Zhang, Jianying and Lund, Solveig Osnes and Holmen, Helle Graneng and Lüders, Torben and Rowe, Alexander and Berge, Rolf Kristian and Lirussi, Lisa and Lefol, Yohan and Alsøe, Lene and Fang, Evandro Fei and Stray-Pedersen, Asbjørg and Nilsen, Hilde Loge},
title = {Transcriptional Profiling Shows Dampening of Interferon Gene Signatures by NAD+ Augmentation in Ataxia-Telangiectasia},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27135652}
}
EUVIMED